26/08/2025
Thanks to for inviting me to respond to the article in today's .ie on "jabs". The terms "jabs" (or worse yet "skinny jabs" as termed in the travesty of a programme rebroadcast by RTÉ last night) - is not necessarily the best term to describe a medication that patients need for a serious disease.
What does Ozempic for Type 2 Diabetes (T2DM) cost the Irish State? Well, some better questions might include: what does the disease of Type 2 Diabetes cost the Irish State?
It currently costs 12-14% of the total healthcare expenditure, and most of that is spent on complications of diabetes, including repeated hospilisations, specialist care, loss of lower limbs, vision, or kidney complications. And if we arent' paying for Ozempic, patients will still need other medications and healthcare services.
We have to remember that this class of drugs (GLP-1a) was originally developed for the treatment of the disease of T2DM going way back in 2010 (liraglutide).
From a healthcare expenditure point of view, we now know these drugs have a role in decreasing the costs of complications from both diabetes and obesity: arthritis, sleep apnoea, heart disease, cancer, asthma, reflux, certain types of cancer, and liver disease (MASLD), just to name a few for which we have more data almost daily. Which leads to more and more hype.
However, even if we do this calculation, we are REALLY missing the point in all this hype:
We are losing - both in economics and population quality of life - if we continue to mire ourselves in a debate about the merits of these drugs or who should be entitled to get them or who should pay for it. Or continue to watch predatory companies - from slimming clubs to online pill-mills to supplement companies - fall over each other trying to cash in on this hype.
The more we judge patients seeking care or restrict access to these medications, the more we force patients into seeking unsafe alternative care: bariatric surgery abroad (don't do it, please), blackmarket drugs or drugs dispensed via online pill-mills. (and yes, for those bean-counters in the back of the romm, the problems from that will cost the Irish State as well, one way or another)
The discussion we need to have: What are we doing to PREVENT Type 2 Diabetes. What are we doing to PREVENT Obesity? Are we addressing food deserts, poor health literacy, urban environments, poverty, ultra-processed food, obesogenic environments? There is a link between inadequate mental health services and obesity (trauma, eating disorders, and medication-associated weight gain). What are we doing to ensure access to safe, whole-person, evidence-based PREVENTATIVE care for patients? Do patients have access to the intensive and comprehensive care that is needed to support an option to put their diabetes into remission rather than just "controlled"?